Literature DB >> 10562543

E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination.

M W Quong1, D P Harris, S L Swain, C Murre.   

Abstract

The basic helix-loop-helix protein, E2A, is required for proper early B lymphopoiesis. Specifically, in E2A-deficient mice, B-cell development is blocked at the progenitor stage prior to the onset of immunoglobulin (Ig) V(D)J recombination. Here, we demonstrate that E2A plays an additional role during peripheral B lymphopoiesis. Upon activation of primary mature B lymphocytes, both E2A protein levels and DNA-binding activity are induced. Furthermore, we show that mature B cells, expressing a dominant-negative E2A antagonist, proliferate normally in response to mitogenic signaling and appropriately express the early and late activation markers CD69, CD44, IgD and B220. However, in the absence of E2A activity, B lymphocytes are blocked in their ability to express secondary Ig isotypes. We demonstrate that the defect lies at the level of DNA rearrangements between the Ig switch regions. These data suggest that E2A is an essential target during B-cell activation and its induction is required to promote Ig class switch recombination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562543      PMCID: PMC1171694          DOI: 10.1093/emboj/18.22.6307

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

Review 1.  Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms.

Authors:  M E Massari; C Murre
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development.

Authors:  Toni Portis; Richard Longnecker
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 3.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

4.  IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice.

Authors:  Huixian Hong; Min Gao; Qi Wu; PingAr Yang; Shanrun Liu; Hao Li; Peter D Burrows; Daniel Cua; Jake Y Chen; Hui-Chen Hsu; John D Mountz
Journal:  J Immunol       Date:  2020-06-17       Impact factor: 5.422

5.  Cytokine profile and insulin antibody IgG subclasses in patients with recent onset type 1 diabetes treated with oral insulin.

Authors:  L Monetini; M G Cavallo; E Sarugeri; F Sentinelli; L Stefanini; E Bosi; R Thorpe; P Pozzilli
Journal:  Diabetologia       Date:  2004-10-22       Impact factor: 10.122

Review 6.  Age effects on mouse and human B cells.

Authors:  Bonnie B Blomberg; Daniela Frasca
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 7.  Metabolic Regulation of the Immune Humoral Response.

Authors:  Mark Boothby; Robert C Rickert
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

8.  Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts.

Authors:  Sujatha Nagulapalli; Aisha Goheer; Leslie Pitt; Lawrence P McIntosh; Michael L Atchison
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

9.  Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development.

Authors:  Babacar Cisse; Michele L Caton; Manfred Lehner; Takahiro Maeda; Stefanie Scheu; Richard Locksley; Dan Holmberg; Christiane Zweier; Nicolette S den Hollander; Sarina G Kant; Wolfgang Holter; Anita Rauch; Yuan Zhuang; Boris Reizis
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

10.  Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.

Authors:  Yulia N Demchenko; Oleg K Glebov; Adriana Zingone; Jonathan J Keats; P Leif Bergsagel; W Michael Kuehl
Journal:  Blood       Date:  2010-01-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.